292 related articles for article (PubMed ID: 15374853)
1. Refractory adult onset Still's disease successfully treated with anakinra.
Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
[No Abstract] [Full Text] [Related]
2. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
[TBL] [Abstract][Full Text] [Related]
3. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
[No Abstract] [Full Text] [Related]
4. [Anakinra in refractory adult onset Still's disease].
Vercoutere W; Starmans-Kool M; Peeters RM
Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
[No Abstract] [Full Text] [Related]
6. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
[No Abstract] [Full Text] [Related]
7. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
[No Abstract] [Full Text] [Related]
8. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Nordström D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T
J Rheumatol; 2012 Oct; 39(10):2008-11. PubMed ID: 22859346
[TBL] [Abstract][Full Text] [Related]
9. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease.
Woo P
Ann Rheum Dis; 2008 Mar; 67(3):281-2. PubMed ID: 18292104
[No Abstract] [Full Text] [Related]
10. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
[No Abstract] [Full Text] [Related]
11. A patient's wish: anakinra in pregnancy.
Berger CT; Recher M; Steiner U; Hauser TM
Ann Rheum Dis; 2009 Nov; 68(11):1794-5. PubMed ID: 19822718
[No Abstract] [Full Text] [Related]
12. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
Raffeiner B; Botsios C; Dinarello C; Ometto F; Punzi L; Ramonda R
Joint Bone Spine; 2011 Jan; 78(1):100-1. PubMed ID: 21036649
[No Abstract] [Full Text] [Related]
15. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease.
Quartuccio L; De Vita S
J Rheumatol; 2007 Apr; 34(4):892-3. PubMed ID: 17407250
[No Abstract] [Full Text] [Related]
16. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
Youssef J; Lazaro E; Blanco P; Viallard JF
J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
[No Abstract] [Full Text] [Related]
17. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
[No Abstract] [Full Text] [Related]
18. A case of refractory adult-onset Still's disease treated with anakinra.
Lahiri M; Teng GG
Int J Rheum Dis; 2010 Aug; 13(3):e36-41. PubMed ID: 20704609
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of anakinra in a case of refractory Still disease.
Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
[No Abstract] [Full Text] [Related]
20. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
